Your session is about to expire
← Back to Search
Testosterone Replacement Therapy for Prostate Cancer
Study Summary
This trial will test whether testosterone replacement therapy can improve the symptoms and quality of life for men who have had their prostate removed.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have recently taken certain medications.I am a man diagnosed with a major psychiatric disorder.I am a man with early-stage prostate cancer, low Gleason score, low PSA before surgery, and stable PSA for 2 years post-surgery.My morning testosterone levels are low.My heart condition is not well-managed.I am 40 years old or older.My A1c level is above 7.5% or I need insulin for my diabetes.I experience sexual dysfunction, fatigue, or physical issues.I have depression that has not been treated.I am a man who has received radiation therapy.I am a man currently undergoing hormone therapy for cancer.I have severe sleep apnea that hasn't been treated.I have not had a recent heart attack, stroke, or any heart surgery.
- Group 1: Treatment Arm
- Group 2: Control Arm
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How secure is Treatment Arm in protecting the well-being of patients?
"Treatment Arm was given a safety rating of 2, as it has progressed to Phase 2. Although there is data that proves its safety, efficacy still remains untested."
What is the upper limit of participants included in this research initiative?
"Affirmative. Clinicaltrials.gov reveals that this medical trial, initially published on March 19th 2019, is actively searching for participants. In total, 142 people are expected to be recruited across 4 distinct sites."
What primary illness is Treatment Arm typically prescribed to treat?
"Treatment Arm is a prescribed intervention for orchiectomy and other medical problems such as hypergonadotropic hypogonadism, testicular hypogonadism, and pituitary gonadotropin hypofunction."
To what extent has Treatment Arm been researched in the past?
"Treatment Arm was initially assessed in 2018 at the Fred Hutch/University of Washington Cancer Consortium. As of now, 18330 trials have been concluded. Currently, 5 investigations are actively taking place with many based in Boston, MA."
Is enrollment still an option for this trial?
"Correct. This trial is actively enrolling eligible participants, with recruitment beginning on March 19th 2019 and the most recent changes to the study posted on July 29th 2022."
Is this a pioneering research endeavor?
"Presently, 5 live clinical trials for Treatment Arm are running simultaneously across 9 cities and 2 countries. This project was initiated in 2018 by AstraZeneca with 36 test subjects who completed Phase 2 of the drug approval process. From that point forward, a total of 18330 investigations have been conducted."
Share this study with friends
Copy Link
Messenger